Romosozumab for Osteoporosis User Reviews (Page 3)
Brand names: Evenity
Romosozumab has an average rating of 6.1 out of 10 from a total of 49 reviews for the treatment of Osteoporosis. 45% of reviewers reported a positive experience, while 29% reported a negative experience.
Reviews for Romosozumab
- Jane
- Taken for 1 to 2 years
- June 6, 2024
Evenity (romosozumab) "It has increased my bone mass and has grown stronger bones."
- Catch
- Taken for 6 months to 1 year
- May 29, 2024
Evenity (romosozumab) "Both upper arms swell around injection site, red & hot to touch for three days after injections."
Frequently asked questions
- Barb
- Taken for 6 months to 1 year
- May 11, 2024
Evenity (romosozumab) "I will require a DEXA scan in August to see if it has had some benefit. Side effects were soreness at the site of injection. Muscle tightness and pain."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Osteoporosis
Care guides
Symptoms and treatments
More about romosozumab
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous bone resorption inhibitors
- En español
"I have been taking this medication for 4 months and have not had any side effects."